Central Nervous System International Prognostic Index (CNS-IPI)

Loading...

References

  1. T A Eyre. Lymphomas: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.. Annals of oncology : official journal of the European Society for Medical Oncology, 2025
  2. Elisabeth Reuben Tolley. Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study.. Blood advances, 2025
  3. Waleed Alduaij. CNS relapse in high-grade B-cell lymphoma with MYC and BCL2 rearrangements and dark-zone signature-expressing DLBCL.. Blood, 2025
  4. J. Jelicic. Prognostic indices in diffuse large B-cell lymphoma: a population-based comparison and validation study of multiple models. Blood Cancer Journal, 2023
  5. M. Klanova. Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL.. Blood, 2019
  6. T. Fischer. Real Life CNS-IPI Score Validation: A Retrospective Analysis of Two Centers in Brazil Outside of Clinical Trial. Blood, 2019
  7. N. Schmitz. CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016
  8. Reference - 10.1200/JCO.2015.65.6520\
  9. Reference - 10.1016/j.annonc.2025.07.014\
  10. Reference - 10.1182/blood.2021014506\
  11. Reference - 10.1002/ajh.26181\
  12. Reference - 10.1111/bjh.19686\